Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
- RxCUI
- 994007
- RxNorm name
- Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
- Display name
- Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
- Full name
- Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9513589d-ef5d-4b8d-a90a-6adb6af2ae11 | Vimovo 375 MG / 20 MG Delayed Release Oral Tablet [PSN] · esomeprazole 20 MG / naproxen 375 MG Delayed Release Oral Tablet [Vimovo] [SBD] · Vimovo 375/20 (naproxen 375 MG / esomeprazole magnesium trihydrate 22.3 MG) Delayed Release Oral Tablet [SY] · Vimovo 375/20 Delayed Release Oral Tablet [SY] | 4 | 1 | These highlights do not include all the information needed to use VIMOVO safely and effectively. See full prescribing information for VIMOVO. VIMOVO ® (naproxen and esomeprazole magnesium) DELAYED RELEASE TABLETS Initial U.S. Approval: April 2010 | 20110729 |